The present invention is related to compounds, compositions and methods of treating viral infections. Compounds of the present invention have the following general formula: ##STR1## wherein R is selected from --CH.sub.2 OH, --CO.sub.2 R.sup.2, --CONR.sup.3 R.sup.4, or COR.sup.5, wherein R.sup.2 is hydrogen or a lower alkyl group, R.sup.3 and R.sup.4 are each independently hydrogen or a lower alkyl group, R.sup.5 is an amino acid residue bound via a terminal nitrogen or peptide having at least two amino acid residues; and wherein R.sup.1 is C.sub.5 -C.sub.13 alkyl, aryl, aralkyl, aralkyl(lower alkyl) ether, or C.sub.5 -C.sub.13 alkyl (lower alkyl)ether.
本发明涉及化合物、组合物和治疗病毒感染的方法。本发明的化合物具有以下通用式:##STR1## 其中R从--CH.sub.2 OH、--CO.sub.2 R.sup.2、--CONR.sup.3 R.sup.4或COR.sup.5中选择,其中R.sup.2是氢或低级烷基,R.sup.3和R.sup.4各自独立地是氢或低级烷基,R.sup.5是通过末端氮或至少具有两个
氨基酸残基的肽结合的
氨基酸残基;R.sup.1是C.sub.5-C.sub.13烷基、芳基、芳基烷基、芳基烷基(低级烷基)醚或C.sub.5-C.sub.13烷基(低级烷基)醚。